Cargando…
Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies
Similar molecular and genetic aberrations among diseases can lead to the discovery of jointly important treatment options across biologically similar diseases. Oncologists closely looked at several hormone-dependent cancers and identified remarkable pathological and molecular similarities in their D...
Autores principales: | Munj, Seeya Awadhut, Taz, Tasnimul Alam, Arslanturk, Suzan, Heath, Elisabeth I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792769/ https://www.ncbi.nlm.nih.gov/pubmed/36583025 http://dx.doi.org/10.3389/fgene.2022.1015531 |
Ejemplares similares
-
Integration of Multimodal Data from Disparate Sources for Identifying Disease Subtypes
por: Zhou, Kaiyue, et al.
Publicado: (2022) -
Discovery of primary prostate cancer biomarkers using cross cancer learning
por: Zhou, Kaiyue, et al.
Publicado: (2021) -
Network Crosstalk as a Basis for Drug Repurposing
por: Guala, Dimitri, et al.
Publicado: (2022) -
Corrigendum: Network Crosstalk as a Basis for Drug Repurposing
por: Guala, Dimitri, et al.
Publicado: (2022) -
Editorial: Artificial Intelligence in Bioinformatics and Drug Repurposing: Methods and Applications
por: Zheng, Pan, et al.
Publicado: (2022)